| Date | Title | Description |
| 04.03.2024 | Radiotherapy Market Trends, Size, Share, Growth, Advancements, Innovations and Forecast 2030 | Radiotherapy Market
Radiotherapy Market to Surpass USD 9.44 Billion by 2030 Driven by Increasing Cancer Incidence and Government Initiatives AUSTIN, TEXAS, UNITED STATES, March 4, 2024 /EINPresswire.com/ -- According to SNS Insider, the Rad... |
| 05.05.2022 | ViewRay Named “Best Overall MedTech Company” in 2022 MedTech Breakthrough Awards Program | "We make medical products that we would be proud to have used on our loved ones" - Scott Drake, President and CEO, ViewRay
CLEVELAND (PRWEB) May 05, 2022
ViewRay, Inc. (NASDAQ: VRAY) today announced that it has been named “Best Ov... |
| 15.12.2021 | ViewRay : Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features - Form 8-K | ViewRay Receives 510(k) Clearance on Next Generation of MRIdian MRI-Guided Radiation Therapy Features
MRIdian A3i and Brain Treatment Package Enhance On-Table Adaptive Workflow and Expand Clinical Utility
CLEVELAND, December 15, 2021-ViewRa... |
| 28.10.2021 | New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting - Form 8-K | New Outcomes Data Demonstrating Prolonged Survival for Inoperable Pancreatic Cancer Patients Presented at Leading Radiation Oncology Meeting
Findings Show Median Overall Survival Of 26 Months for Patients Receiving Ablative Doses with MRIdi... |
| 29.09.2021 | ViewRay : Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations (Form 8-K) | ViewRay Announces 510(k) Pending Status of the Newest Generation of MRIdian Innovations
New suite of workflow and clinical features to be highlighted at upcoming ASTRO 2021 conference
CLEVELAND, OH, September 29, 2021-ViewRay, Inc. (NASDAQ:... |
| 24.08.2021 | Amsterdam University Medical Centers establishes same-day ablative treatment service using MRIdian® to Streamline the Patient Experience. | |
| 17.08.2021 | UCLA Health Treats its 1,000th Patient Using MRIdian® MRI-Guided Radiation Therapy | |
| 05.08.2021 | ViewRay Reports Second Quarter 2021 Results | |
| 15.07.2021 | ViewRay Announces Conference Call for Second Quarter 2021 Financial Results to be Held After Market on August 5, 2021 | |
| 07.07.2021 | Miami Cancer Institute Enrolls First Patients in Single-Fraction Stereotactic MRI-Guided Adaptive Radiation Therapy for Inoperable Primary or Metastatic Cancer Trial | |
| 24.06.2021 | GenesisCare Expands their MR-guided Radiotherapy Reach with the Purchase of Multiple MRIdian® Systems | |
| 11.06.2021 | ViewRay Announces Election of Karen N. Prange to its Board of Directors | |
| 25.05.2021 | American Hospital in Istanbul, Turkey Purchases MRIdian® MRI-Guided Radiation Therapy System | |
| 06.05.2021 | ViewRay Reports First Quarter 2021 Results | |
| 19.04.2021 | ViewRay Announces Conference Call for First Quarter 2021 Financial Results to be Held After Market on May 6, 2021 | |
| 15.03.2021 | ViewRay Announces Departure of Chief Operating Officer | |
| 04.03.2021 | ViewRay Reports Fourth Quarter and Full Year 2020 Results | |
| 19.02.2021 | ViewRay Announces Conference Call for Fourth Quarter and Full Year 2020 Financial Results to be Held After Market on March 4, 2021 | |
| 11.02.2021 | ViewRay Announces Appointment of Phil Spencer to its Board of Directors | |
| 11.02.2021 | Penn State Health Purchases Second ViewRay MRIdian® Linac | |
| 26.01.2021 | The Henry Ford Cancer Institute Installs its Second ViewRay MRIdian® Linac | |
| 15.01.2021 | ViewRay Announces Participation in the B. Riley Oncology Investor Conference | |
| 07.01.2021 | ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock | |
| 04.01.2021 | ViewRay Announces Proposed Public Offering of Common Stock | |
| 04.01.2021 | ViewRay Announces Preliminary Fourth Quarter and Full Year 2020 Results | |
| 22.12.2020 | Seoul National University Hospital Treats 1,000th Patient with MRIdian MRI-Guided Radiation Therapy | |
| 21.12.2020 | Eindhoven's Catharina Hospital Purchases ViewRay's MRIdian Linac
USA - English
Nederland - Nederlands | |
| 12.11.2020 | Amsterdam University Medical Centers Treats 1,000th Patient with MRIdian SMART MRI-Guided Radiation Therapy
USA - English
Nederland - Nederlands
France - Français | |
| 10.11.2020 | Leading Academic Clinical Training Hospital, Universitair Ziekenhuis Brussels, Purchases ViewRay's MRIdian Linac
USA - English
Nederland - Nederlands
France - Français | |
| 21.10.2020 | ASTRO 2020 to Feature Latest MRIdian Clinical Experience Highlighting Outcomes in Tough to Treat Cancer | |
| 15.10.2020 | ViewRay Announces Conference Call for Third Quarter 2020 Financial Results to be Held After Market on November 5, 2020 | |
| 14.10.2020 | Louis Stokes Cleveland VA Medical Center Purchases ViewRay's MRIdian Linac for MRI-Guided Radiation Therapy | |
| 01.10.2020 | ViewRay to Host Physician-led Webinar for Investors and Analysts at the 2020 American Society of Radiation Oncology (ASTRO) Annual Meeting | |
| 24.09.2020 | Chungnam National University Sejong Hospital Begins Patient Treatments with ViewRay's MRIdian Linac | |
| 27.08.2020 | ViewRay, GenesisCare and the University of Oxford Announce Groundbreaking Compassionate Access Programme Now Open to UK Patients with Localized Pancreatic Cancer | |
| 13.08.2020 | Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay's MRIdian Linac | |
| 13.07.2017 | Elekta bets MRI is the next step in radiotherapy | The challenge with radiation, and other cancer therapies, is getting the right amount of treatment to the tumor and leaving healthy cells unscathed. Image-guided technologies have fueled the evolution towards more targeted radiotherapy. Sti... |
| 18.01.2017 | Puissance Capital Leads $26.1M for ViewRay | ViewRay, Inc. (Nasdaq: VRAY), makers of the world's first and only clinical MRI-guided radiation therapy system, announced today that it has raised aggregate gross proceeds of approximately $26.1 million through a private placement of its c... |
| 20.08.2015 | ViewRay Completes Private Placement, Raises Aggregate of $29.4Million | - |
| 23.07.2015 | ViewRay Completes Alternative Public Offering, Raises $26.7 Million | Funding to Support Further Innovation and Commercialization of MRI-Guided Radiation Therapy System
July 23, 2015
CLEVELAND — July 23, 2015 — ViewRay, Inc. (OTCQB: VRAY) announced today its successful completion of a reverse merger with Vi... |
| 30.06.2015 | ViewRay Secures up to $50M in Debt Financing | ViewRay, a Cleveland, Ohio-based maker of a clinical MRI-guided radiation therapy system, secured up to $50 million in debt financing.
CRG (formerly Capital Royalty L.P.), a premier healthcare investment firm, provides the financing.
This d... |
| 30.06.2015 | ViewRay Secures Up To $50M in Debt Financing From CRG | Funding to Drive Global Expansion of its MRI-Guided Radiation Therapy Business
June 30, 2015
CLEVELAND, June 30, 2015 — ViewRay™, makers of MRIdian™, the world’s first and only clinical MRI-guided radiation therapy system, announced today... |
| 17.04.2015 | ViewRay rescinds $52m IPO | ViewRay yesterday became the latest medical device company to scrap an initial public offering, withdrawing a flotation that would have raised $52 million for its MRI-guided radiation therapy technology.
Oakwood Village, Ohio-based ViewRay ... |
| 16.04.2015 | ViewRay tables $52m IPO | Medtech Wall Street news for the week of April 13, 2015 | Report: ViewRay tables $52m IPO April 9, 2015 by Brad Perriello
ViewRay postponed its initial public offering with which it planned to raise $52 million for its MRI-guided radiation therapy technology, Renaissance Capital reported.
Oakwood ... |
| 09.04.2015 | Report: ViewRay tables $52m IPO | ViewRay postponed its initial public offering with which it planned to raise $52 million for its MRI-guided radiation therapy technology, Renaissance Capital reported.
Oakwood Village, Ohio-based ViewRay had planned to float 4 million share... |
| 13.03.2015 | ViewRay sets $52m IPO terms | ViewRay today set the terms for its pending initial public offering, saying it plans to float 4 million shares at $12 to $14 apiece.
At the midpoint of the range, the MRI-guided radiation therapy maker’s IPO would fetch $52 million.
That’s ... |
| 16.02.2015 | ViewRay registers for $69m IPO | ViewRay last week said it plans to raise up to $69 million in an initial public offering for its MRIdian system, which it bills as "the 1st and only MRI-guided radiation therapy system that images and treats cancer patients simultaneou... |
| 17.12.2013 | ViewRay Closes a $30M Financing to Expedite Commercialization of its MRI-Guided Radiation Therapy System | CLEVELAND, Dec. 17, 2013 /PRNewswire/ — ViewRay™ Incorporated, a privately held medical device company, has secured $30 million in funding from existing equity investors, Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and Or... |
| 17.12.2013 | ViewRay Secures $30M | ViewRay Incorporated, a Cleveland, Ohio-based medical device company, secured $30m in funding.
Backers included existing equity investors Aisling Capital, Fidelity Biosciences, Kearny Venture Partners and OrbiMed Advisors, and new investor ... |
| 22.05.2013 | ViewRay Raises $15M in Funding | According to PeHub (read here), ViewRay Inc., a Cleveland, OH-based medical device company, raised $15m in funding.
Investors were not named.
Founded in 2004 and led by Chris A. Raanes, President and CEO, James F. Dempsey, PhD, Chief Scient... |
| 20.05.2013 | ViewRay closes in on $17.4M round | ViewRay Inc. has $2.4 million to go to reach its goal for a $17.4 million funding round.
Seven investors are in on the offering, and $15 million had been sold at the time the company disclosed the funding round May 8, according to a regulat... |
| 13.03.2012 | MRI-guided radiotherapy firm ViewRay closes last tranche of $45M series C | The latest tranche of funding consisted of $16 million, ViewRay chief financial officer David Chandler told Crain’s Cleveland Business. The company plans to use the funding to beef up its sales and marketing in anticipation of its product l... |
| 13.03.2012 | ViewRay Closes $45M Series C Venture Capital Financing | ViewRay Inc., a Cleveland, Ohio-based medical device company, has closed a $45m round of Series C venture capital financing.
Backers include Aisling Capital, Fidelity Biosciences, Kearny Venture Partners, OrbiMed Advisors and Siemens Ventur... |
| 13.03.2012 | ViewRay Closes $45M Round of Series C |
CLEVELAND, OH, Medical device company has closed the final tranche of a $45 million round of Series C round. Institutional investors include Aisling Capital, Fidelity Biosciences, Kearny Venture Partners, OrbiMed Advisors and Siemens Vent... |
| 30.08.2011 | MRI-guided radiotherapy firm ViewRay gets $10M in new funding | The new funding was sourced from 15 investors and came in the form of convertible notes.
It’s unclear whether the new funding is the beginning of a formal series D round, or just some cash to tide the company over until it begins commercial... |
| 22.02.2011 | ViewRay wins FDA 510(k) clearance for MRI-based radiotherapy technology | ViewRay Inc. received federal regulatory clearance to begin commercializing its MRI-based technology to deliver radiation therapy to cancer patients.
The Oakwood, Ohio-based company’s imaging device received clearance under the Food & D... |
| 21.02.2011 | ViewRay gets FDA clearance for MRI-guided radiotherapy device | The 510(k) clearance is a big milestone for the company as it looks to begin generating sales — and returns for the investors who’ve pushed $53 million into ViewRay. In August, the company announced that it had raised a $20 million Series C... |
| 25.08.2010 | Radiation therapy firm ViewRay grabs $20M Series C investment | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R... |
| 25.08.2010 | ViewRay Raises $20M in Series C Financing | ViewRay, Inc., a Cleveland, Ohio-based medical device company developing advanced radiation therapy technology for the treatment of cancer, has secured $20m in Series C financing.
The round was led by new investor Siemens Venture Capital, w... |
| 25.08.2010 | ViewRay drums up a $20 million Series C round | ViewRay Inc., which is developing MRI-based technology to deliver radiation therapy to cancer patients, drummed up $20 million in a Series C equity offering.
The company is in the late stages of developing its technology and the funding wil... |
| 15.02.2010 | NorTech to honor 3 bioscience innovations with 2010 awards | The bioscience projects to be honored Feb. 24 at LaCentre Conference and Banquet Facility in Westlake, Ohio are:
Renaissance System 1000 — ViewRay Inc., a company that moved to Oakwood Village, Ohio from Florida in 2008, is developing radia... |
| 14.04.2009 | ViewRay gets second tranche of $25 million investment, cinches Siemens partnership | ViewRay moved to Oakwood in suburban Cleveland last year, lured both by the region’s imaging talent and tax incentives. The Ohio Tax Credit Authority gave the company job creation tax credits worth about $537,000 over the next 10 years. V... |
| 18.02.2009 | Growth of contract organizations, startups helping Ohio’s national profile as a bioscience innovator | The outsourced work added up to more revenues, jobs and growth at contract research organizations like Ricerca Biosciences in Concord Township and contract manufacturing organizations like Ben Venue Laboratoriesin Bedford.Â
Ricerca, which... |
| 22.01.2008 | Life sciences briefing: Tuesday, Jan. 22, 2007 | TODAY’S HEADLINES:
Teva acquires protein-therapeutic maker CoGenesys for $400M (release)
ViewRay takes in $25M for MRI radiation-therapy guidance (release)
NovaMed, Chinese clinical-research outfit, receives $14M (release)
Progentix Ortho r... |
| 08.08.2007 | Life sciences briefing: Wednesday, Aug. 8, 2007 | Featured companies: NeurAxon, TechniScan Medical Systems, ViewRay, Advion BioSystems, NanoTek, Cerionx, Ionscope, EncorePath
NeurAxon to raise $25M for pain treatment — Waltham, Mass.-based NeurAxon, which just named Lawrence Bloch as its n... |
| - | Elekta bets MRI is the next step in radiotherapy | Woman receiving radiation therapy treatments for cancer
Stockholm-based Elekta has begun clinical trials on its Unity machine, which combines a linear accelerator and high-field magnetic resonance imaging (MRI) to better define and track tu... |
| - | Growth of contract organizations, startups helping Ohio’s national profile as a bioscience innovator | Two trends helped give Ohio a seat at the bioscience leaders table last year, according to Tony Dennis, president and chief executive of BioOhio, the state’s bioscience company developer.
Big drug companies farmed out more of their rese... |
| - | MRI-guided radiotherapy firm ViewRay closes last tranche of $45M series C | A company that’s developing MRI-based technology to deliver radiation therapy to cancer patients has closed the last tranche of a $45 million series C round of investment as it nears commercialization.
Cleveland-area ViewRay is preparing fo... |
| - | ViewRay gets FDA clearance for MRI-guided radiotherapy device | ViewRay has received federal regulatory clearance to begin commercializing its MRI-based technology to deliver radiation therapy to cancer patients.
The Oakwood, Ohio-based company’s imaging device received clearance under the U.S. Food and... |
| - | Radiation therapy firm ViewRay grabs $20M Series C investment | ViewRay Inc., which is developing MRI-based technology to deliver radiation therapy to cancer patients, has secured a $20 million Series C funding round.
The company is in the late stages of developing its technology, and the funding will b... |
| - | ViewRay gets second tranche of $25 million investment, cinches Siemens partnership | OAKWOOD, Ohio — The Cleveland-area medical device company ViewRay said today it received an additional $15 million of the $25 million Series B financing it had announced in January (pdf). In addition, the company stated it has partnered wit... |
| - | NorTech to honor 3 bioscience innovations with 2010 awards | CLEVELAND, Ohio — Northeast Ohio’s technology economic development organization, NorTech, has chosen three bioscience products to receive its 2010 Innovation Awards.
The annual awards recognize innovation achievements of the region’s organi... |
| - | MRI-guided radiotherapy firm ViewRay gets $10M in new funding | A company that’s developing MRI-based technology to deliver radiation therapy to cancer patients has secured $10 million in new investment funding.
Oakwood Village, Ohio-based ViewRay‘s $10.3 million fundraise comes from existing investors,... |
